Alnylam Pharmaceuticals
ALNY
#567
Rank
ยฃ28.46 B
Marketcap
ยฃ220.85
Share price
-2.26%
Change (1 day)
63.82%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company